Moreover, TM4SF1 expression was positively correlated with integrin α6 and p-FAK expression, and activated TM4SF1/integrin α6/FAK signaling axis is correlated with poor survival in ESCC patients. Here, PTK2 is linked to esophageal squamous cell carcinoma.